These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 14638957)
1. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Balcer LJ; Baier ML; Cohen JA; Kooijmans MF; Sandrock AW; Nano-Schiavi ML; Pfohl DC; Mills M; Bowen J; Ford C; Heidenreich FR; Jacobs DA; Markowitz CE; Stuart WH; Ying GS; Galetta SL; Maguire MG; Cutter GR Neurology; 2003 Nov; 61(10):1367-73. PubMed ID: 14638957 [TBL] [Abstract][Full Text] [Related]
2. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814 [TBL] [Abstract][Full Text] [Related]
3. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503 [TBL] [Abstract][Full Text] [Related]
4. Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis. Schinzel J; Zimmermann H; Paul F; Ruprecht K; Hahn K; Brandt AU; Dörr J BMC Neurol; 2014 Feb; 14():31. PubMed ID: 24555757 [TBL] [Abstract][Full Text] [Related]
5. Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients. Wender M Neurol Neurochir Pol; 2007; 41(2):141-3. PubMed ID: 17530576 [TBL] [Abstract][Full Text] [Related]
7. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS. Moster S; Wilson JA; Galetta SL; Balcer LJ J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088 [TBL] [Abstract][Full Text] [Related]
8. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome measures for research in multiple sclerosis. Balcer LJ J Neuroophthalmol; 2001 Dec; 21(4):296-301. PubMed ID: 11756863 [TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of two new contrast sensitivity charts. Thayaparan K; Crossland MD; Rubin GS Br J Ophthalmol; 2007 Jun; 91(6):749-52. PubMed ID: 17166891 [TBL] [Abstract][Full Text] [Related]
11. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Balcer LJ; Raynowska J; Nolan R; Galetta SL; Kapoor R; Benedict R; Phillips G; LaRocca N; Hudson L; Rudick R; Mult Scler; 2017 Apr; 23(5):734-747. PubMed ID: 28206829 [TBL] [Abstract][Full Text] [Related]
12. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Balcer LJ; Baier ML; Pelak VS; Fox RJ; Shuwairi S; Galetta SL; Cutter GR; Maguire MG Mult Scler; 2000 Jun; 6(3):163-71. PubMed ID: 10871827 [TBL] [Abstract][Full Text] [Related]
13. Test-retest Repeatability of the Ohio Contrast Cards. Osman M; Njeru SM; Hopkins GR; Brown AM Optom Vis Sci; 2021 Sep; 98(9):1070-1077. PubMed ID: 34570031 [TBL] [Abstract][Full Text] [Related]
14. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. Mowry EM; Loguidice MJ; Daniels AB; Jacobs DA; Markowitz CE; Galetta SL; Nano-Schiavi ML; Cutter GR; Maguire MG; Balcer LJ J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):767-72. PubMed ID: 19240050 [TBL] [Abstract][Full Text] [Related]
15. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Balcer LJ; Frohman EM Neurology; 2010 Apr; 74 Suppl 3():S16-23. PubMed ID: 20421569 [TBL] [Abstract][Full Text] [Related]
16. Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. Lynch DR; Farmer JM; Rochestie D; Balcer LJ J Neuroophthalmol; 2002 Dec; 22(4):270-4. PubMed ID: 12464730 [TBL] [Abstract][Full Text] [Related]
17. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies. Ozakbas S; Ormeci B; Idiman E J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Miller DM; Rudick RA; Cutter G; Baier M; Fischer JS Arch Neurol; 2000 Sep; 57(9):1319-24. PubMed ID: 10987899 [TBL] [Abstract][Full Text] [Related]
19. Predictors of vision impairment in Multiple Sclerosis. Sanchez-Dalmau B; Martinez-Lapiscina EH; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Blanco Y; Sola-Valls N; Sepulveda M; Guerrero A; Alba S; Andorra M; Camos A; Sanchez-Vela L; Alfonso V; Saiz A; Villoslada P PLoS One; 2018; 13(4):e0195856. PubMed ID: 29664921 [TBL] [Abstract][Full Text] [Related]
20. Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients. Soler García A; González Gómez A; Figueroa-Ortiz LC; García-Ben A; García-Campos J Arch Soc Esp Oftalmol; 2014 Sep; 89(9):347-51. PubMed ID: 24954414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]